News

AbbVie Inc. (NYSE:ABBV) is one of the 12 best healthcare stocks to buy now. On June 12, the US Food and Drug Administration (FDA) approved the company’s Mavyret treatment label expansion. The approval ...
President Trump just issued an executive order to rebalance the global pharmaceutical market — by tying U.S. drug prices to ...
President Trump just issued an executive order to rebalance the global pharmaceutical market -- by tying U.S. drug prices to the artificially low, government-set prices in other developed nations.
Starting July 7, 2025, the two highest doses of Zepbound will be available for a flat price of $499 per month, with shipments ...
The cost of staying alive could become a lot more expensive for millions of Americans because of Trump drug tariffs - Are you ...
Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...
While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...
Ebony Price, a recent graduate of the Women's Empowerment program, shares her journey from drug addiction to becoming a peer ...
Ascendis Pharma A/S (NASDAQ:ASND) is one of the best 52-week high stocks to buy, according to analysts. On June 9, BofA ...
Eli Lilly is reducing the price of the highest doses of its popular drug Zepbound for folks who aren't using insurance.
Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...
Merck ( MRK) is a global biopharmaceutical giant with a diversified portfolio that spans across oncology, vaccines, ...